Systemic inflammatory response index as an independent predictor of all-cause mortality in patients receiving maintenance hemodialysis: a retrospective cohort study
- 1Department of Internal Medicine, Gaziosmanpaşa Training and Research Hospital, Istanbul, Türkiye
- 2Department of Internal Medicine, Haseki Health Training and Research Hospital, University of Health Sciences Turkey, İstanbul, Türkiye
- 3Department of Internal Medicine, Istanbul Medipol University, Istanbul, Türkiye
Abstract
Purpose: Chronic kidney disease (CKD) represents a major global public health burden, with affected individuals facing substantially elevated risks of morbidity, mortality, and healthcare resource utilization. In this context, the present study was undertaken to evaluate the prognostic value of the systemic inflammatory response index (SIRI) in patients undergoing maintenance hemodialysis.
Patients and methods: A total of 534 maintenance hemodialysis patients were included in the study. The median follow-up duration was 26.0 months. The primary endpoint of this study was all-cause mortality. We compared a comprehensive panel of laboratory parameters between the survival and non-survival groups, including metabolic markers (serum triglycerides, total cholesterol, uric acid, calcium, sodium, and potassium), renal function indices (serum creatinine and blood urea nitrogen), hematological parameters (hemoglobin, hematocrit, white blood cell, platelet, neutrophil, lymphocyte, and monocyte counts), and inflammatory markers (albumin and C-reactive protein). Furthermore, we derived five composite inflammatory indices from the complete blood count: NLR, PLR, MLR, SIRI, and SII.
Results: During a median follow-up period, 105 of 534 patients (19.7%) died. Compared with survivors, non-survivors were significantly older and exhibited higher levels of inflammatory markers, including CRP and SIRI, along with lower hemoglobin and albumin levels. In multivariate analysis, age, serum potassium, hemoglobin, and SIRI (OR: 1.072, 95% CI: 1.009–1.139, p = 0.025) emerged as independent predictors of all-cause mortality. ROC analysis demonstrated that SIRI had acceptable discriminative ability (AUC: 0.724), with an optimal cut-off value of 2.3, and patients with SIRI ≥2.3 had significantly shorter survival than those with lower values (log-rank p < 0.001).
Conclusion: SIRI demonstrated clinical utility as a novel, readily available biomarker for predicting all-cause mortality in patients undergoing maintenance hemodialysis.
Related
- Blood free carnitine level is an independent determinant of erythrocyte membrane homogeneity and osmotic resistance in maintenance hemodialysis patients
- Pre-admission Nutritional Risk as an Independent Predictor of 28-Day Mortality After Hip Fracture: A Retrospective Cohort Study
- Association of Maintenance Hemodialysis with Transfer to Post-Acute Rehabilitation After Stroke: A Single-Center Retrospective Cohort Study.
- Changes in Nutritional Status and Bioimpedance Parameters During EAA/KA Supplementation in Elderly Patients Undergoing Maintenance Hemodialysis: A Retrospective Observational Study
- Blood pressure variability and serum sodium for long-term mortality risk stratification in maintenance hemodialysis patients: a real-world retrospective cohort study
BibTeX
@article{tatlı2026systemic,
title = {{Systemic inflammatory response index as an independent predictor of all-cause mortality in patients receiving maintenance hemodialysis: a retrospective cohort study}},
author = {Emel Tatlı and Betül Çavuşoğlu Türker and Süleyman Tuna Yolcu and Emine Ayaz Yolcu and Pınar Doğan and Nilhan İlkun Akdeniz and Mehmet Yamak and Fatih Türker},
journal = {Frontiers in Medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1962923},
url = {https://doi.org/10.3389/fmed.2026.1962923},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Systemic inflammatory response index as an independent predictor of all-cause mortality in patients receiving maintenance hemodialysis: a retrospective cohort study
AU - Emel Tatlı
AU - Betül Çavuşoğlu Türker
AU - Süleyman Tuna Yolcu
AU - Emine Ayaz Yolcu
AU - Pınar Doğan
AU - Nilhan İlkun Akdeniz
AU - Mehmet Yamak
AU - Fatih Türker
PY - 2026
DA - 2026/10/13
JO - Frontiers in Medicine
DO - 10.3389/fmed.2026.1962923
UR - https://doi.org/10.3389/fmed.2026.1962923
AB - Purpose: Chronic kidney disease (CKD) represents a major global public health burden, with affected individuals facing substantially elevated risks of morbidity, mortality, and healthcare resource utilization. In this context, the present study was undertaken to evaluate the prognostic value of the systemic inflammatory response index (SIRI) in patients undergoing maintenance hemodialysis. Patients and methods: A total of 534 maintenance hemodialysis patients were included in the study. The median follow-up duration was 26.0 months. The primary endpoint of this study was all-cause mortality. We compared a comprehensive panel of laboratory parameters between the survival and non-survival groups, including metabolic markers (serum triglycerides, total cholesterol, uric acid, calcium, sodium, and potassium), renal function indices (serum creatinine and blood urea nitrogen), hematological parameters (hemoglobin, hematocrit, white blood cell, platelet, neutrophil, lymphocyte, and monocyte counts), and inflammatory markers (albumin and C-reactive protein). Furthermore, we derived five composite inflammatory indices from the complete blood count: NLR, PLR, MLR, SIRI, and SII. Results: During a median follow-up period, 105 of 534 patients (19.7%) died. Compared with survivors, non-survivors were significantly older and exhibited higher levels of inflammatory markers, including CRP and SIRI, along with lower hemoglobin and albumin levels. In multivariate analysis, age, serum potassium, hemoglobin, and SIRI (OR: 1.072, 95% CI: 1.009–1.139, p = 0.025) emerged as independent predictors of all-cause mortality. ROC analysis demonstrated that SIRI had acceptable discriminative ability (AUC: 0.724), with an optimal cut-off value of 2.3, and patients with SIRI ≥2.3 had significantly shorter survival than those with lower values (log-rank p < 0.001). Conclusion: SIRI demonstrated clinical utility as a novel, readily available biomarker for predicting all-cause mortality in patients undergoing maintenance hemodialysis.
SN - 2296-858X
ER -